The recent COVID-19 pandemic caused by SARS-CoV-2 has affected health care systems and economies around the world and has challenged the development of vaccines, drugs, and diagnostics. Since the outbreak of the epidemic, Creative Biolabs has been actively tracking the changes and movements of the virus to make our products “up to date.” SARS-CoV-2 related antibody products have been widely used by researchers in different disciplines. Scientists actively use mutant proteins to evaluate the phenomenon of “antibody evasion” caused by mutations in key residues in spike proteins.
More details could be seen at: Anti-SARS-CoV-2 S, E, M and N antibodies - Creative Biolabs